Cargando…
Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
Sarcoidosis is a multi‐systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral comp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374215/ https://www.ncbi.nlm.nih.gov/pubmed/34107064 http://dx.doi.org/10.1111/cei.13635 |
_version_ | 1783740069531615232 |
---|---|
author | d’Alessandro, Miriana Bergantini, Laura Cameli, Paolo Mezzasalma, Fabrizio Refini, Rosa Metella Pieroni, Maria Sestini, Piersante Bargagli, Elena |
author_facet | d’Alessandro, Miriana Bergantini, Laura Cameli, Paolo Mezzasalma, Fabrizio Refini, Rosa Metella Pieroni, Maria Sestini, Piersante Bargagli, Elena |
author_sort | d’Alessandro, Miriana |
collection | PubMed |
description | Sarcoidosis is a multi‐systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral compartments. Thirteen patients were selected for the study [median age, interquartile range (IQR) = 57 years (48–59); 23% were male]. Twelve healthy controls [median age, IQR = 53 years (52–65); 16% male] were also enrolled into the study. Cellular and cytokine patterns were measured using the cytofluorimetric approach. Peripheral CD8 percentages were higher in sarcoidosis patients (SP) than healthy controls (HC) (p = 0.0293), while CD4 percentages were lower (p = 0.0305). SP showed low bronchoalveolar lavage (BAL) percentages of CD19 (p = 0.0004) and CD8 (p = 0.0035), while CD19(+)CD5(+)CD27(−) percentages were higher (p = 0.0213); the same was found for CD4 (p = 0.0396), follicular regulatory T cells (T(reg)) (p = 0.0078) and T(reg) (p < 0.0001) cells. Low T helper type 17 (Th17) percentages were observed in BAL (p = 0.0063) of SP. Peripheral CD4(+) C‐X‐C chemokine receptor (CXCR)5(+)CD45RA(−)) percentages and follicular T helper cells (Tfh)‐like Th1 (Tfh1) percentages (p = 0.0493 and p = 0.0305, respectively) were higher in the SP than HC. Tfh1 percentages and Tfh‐like Th2 percentages were lower in BAL than in peripheral blood (p = 0.0370 and p = 0.0078, respectively), while CD4(+) C‐X‐C motif CXCR5(+)CD45RA(−) percentages were higher (p = 0.0011). This is the first study, to our knowledge, to demonstrate a link between an imbalance in circulating and alveolar Tfh cells, especially CCR4‐, CXCR3‐ and CXCR5‐expressing Tfh subsets in the development of sarcoidosis. These findings raise questions about the pathogenesis of sarcoidosis and may provide new directions for future clinical studies and treatment strategies. |
format | Online Article Text |
id | pubmed-8374215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83742152021-08-24 Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers d’Alessandro, Miriana Bergantini, Laura Cameli, Paolo Mezzasalma, Fabrizio Refini, Rosa Metella Pieroni, Maria Sestini, Piersante Bargagli, Elena Clin Exp Immunol ORIGINAL ARTICLES Sarcoidosis is a multi‐systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral compartments. Thirteen patients were selected for the study [median age, interquartile range (IQR) = 57 years (48–59); 23% were male]. Twelve healthy controls [median age, IQR = 53 years (52–65); 16% male] were also enrolled into the study. Cellular and cytokine patterns were measured using the cytofluorimetric approach. Peripheral CD8 percentages were higher in sarcoidosis patients (SP) than healthy controls (HC) (p = 0.0293), while CD4 percentages were lower (p = 0.0305). SP showed low bronchoalveolar lavage (BAL) percentages of CD19 (p = 0.0004) and CD8 (p = 0.0035), while CD19(+)CD5(+)CD27(−) percentages were higher (p = 0.0213); the same was found for CD4 (p = 0.0396), follicular regulatory T cells (T(reg)) (p = 0.0078) and T(reg) (p < 0.0001) cells. Low T helper type 17 (Th17) percentages were observed in BAL (p = 0.0063) of SP. Peripheral CD4(+) C‐X‐C chemokine receptor (CXCR)5(+)CD45RA(−)) percentages and follicular T helper cells (Tfh)‐like Th1 (Tfh1) percentages (p = 0.0493 and p = 0.0305, respectively) were higher in the SP than HC. Tfh1 percentages and Tfh‐like Th2 percentages were lower in BAL than in peripheral blood (p = 0.0370 and p = 0.0078, respectively), while CD4(+) C‐X‐C motif CXCR5(+)CD45RA(−) percentages were higher (p = 0.0011). This is the first study, to our knowledge, to demonstrate a link between an imbalance in circulating and alveolar Tfh cells, especially CCR4‐, CXCR3‐ and CXCR5‐expressing Tfh subsets in the development of sarcoidosis. These findings raise questions about the pathogenesis of sarcoidosis and may provide new directions for future clinical studies and treatment strategies. John Wiley and Sons Inc. 2021-07-07 2021-09 /pmc/articles/PMC8374215/ /pubmed/34107064 http://dx.doi.org/10.1111/cei.13635 Text en © 2021 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | ORIGINAL ARTICLES d’Alessandro, Miriana Bergantini, Laura Cameli, Paolo Mezzasalma, Fabrizio Refini, Rosa Metella Pieroni, Maria Sestini, Piersante Bargagli, Elena Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers |
title | Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers |
title_full | Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers |
title_fullStr | Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers |
title_full_unstemmed | Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers |
title_short | Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers |
title_sort | adaptive immune system in pulmonary sarcoidosis—comparison of peripheral and alveolar biomarkers |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374215/ https://www.ncbi.nlm.nih.gov/pubmed/34107064 http://dx.doi.org/10.1111/cei.13635 |
work_keys_str_mv | AT dalessandromiriana adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT bergantinilaura adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT camelipaolo adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT mezzasalmafabrizio adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT refinirosametella adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT pieronimaria adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT sestinipiersante adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers AT bargaglielena adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers |